"We offer a unique combination of extensive inhalation device development capability and long experience from pharmaceutical product development."
The Swedish Patent and Registration Office, PRV, has granted two ICOres patents. This is a key milestone showing that Iconovo's inhalers are novel and inventive. More patent applications regarding ICOres, ICOcap and ICOone will soon enter the PCT phase.
Iconovo is exhibiting the full range of our dry powder inhalers at Respiratory Drug Delivery, RDD 2016, in Scotsdale, Arizona. Click here for more information about RDD
Iconovo has moved into new offices and labs. We needed more space to handle all the new projects and new equipment. We are still at Medicon Village but now in building 402.